APA (7th ed.) Citation

Oran, B., Thall, P., Alousi, A., Al-Atrash, G., Mehta, R., Marin, D., . . . Champlin, R. Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: Phase II results from a single center. Ferrata Storti Foundation.

Chicago Style (17th ed.) Citation

Oran, Betül, et al. Guadecitabine Improved Relapse-free Survival in High-risk Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients After Transplant: Phase II Results from a Single Center. Ferrata Storti Foundation.

MLA (9th ed.) Citation

Oran, Betül, et al. Guadecitabine Improved Relapse-free Survival in High-risk Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients After Transplant: Phase II Results from a Single Center. Ferrata Storti Foundation.